AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Recent Artery Conversations

Review of Patient Results in Response to a PT Failure

Would anybody be willing to share a copy of their policy/procedure re: the CAP's recommendation to review patient results bracketing a PT failure to see if they were impacted? I am presuming that some have an algorithmic approach to decide when/what requires patient chart review.

Please share

Urine Drug Test

When do you order urine drug tests in hospitals? Who is allowed to order it? Which type of consent is required for which case?

Please share

Cystatin C Reporting

We are planning to bring Cystatin C in house at our organization over the next few months. We have seen steady increases in send out volume over the last few years and it now makes sense. I was curious how others have structured this at their institution in terms of test orderables, panels and the equations used? Our current plan is to make it an individual orderable that calculates eGFR using the 2021 Cystatin C only equation but we have debated making a new renal panel that includes creatinine and cystatin C and uses the 2021 eGFR equation that uses both in that case. Of course with that we have concern about test build complexity and too many equations being used!

Please share


Connect. Grow. Advance.

AACC brings together the world of laboratory medicine to exchange best practices, learn about the latest biomedical science, and network with like-minded professionals from across the globe.